Expedition cruises, island hopping, and zoonotic risk: governance and operational lessons from the MV Hondius Andes hantavirus outbreak - Summary - MDSpire
Advertisement
Expedition cruises, island hopping, and zoonotic risk: governance and operational lessons from the MV Hondius Andes hantavirus outbreak
To analyze the Andes orthohantavirus outbreak linked to the MV Hondius expedition cruise and identify governance and operational gaps in outbreak preparedness for expedition travel.
Approach:
Case Study Analysis: Utilized the MV Hondius outbreak as a case study to assess the intersection of zoonotic exposure and public health challenges in expedition cruises.
Evaluation of Existing Guidelines: Reviewed International Health Regulations, WHO ship-event guidance, and ECDC recommendations to identify gaps in their application to expedition-specific contexts.
Key Findings:
The outbreak involved 13 reported cases and three deaths, with a case fatality ratio of 25%.
Limited person-to-person transmission of Andes virus was documented, which is atypical for orthohantaviruses.
Critical vulnerabilities were identified, including the absence of binding protocols for medical evacuation and a lack of standardized passenger traceability systems.
Interpretation:
The MV Hondius outbreak illustrates the complexities of managing zoonotic diseases in the context of expedition travel.
Limitations:
The analysis is based on a single outbreak case study, which may limit generalizability.
Existing guidelines may not be fully operationalized in remote expedition contexts.
Conclusion:
The outbreak underscores the importance of establishing enforceable preparedness arrangements for expedition cruises.
Heart rate monitoring and atrial fibrillation detection had the strongest supporting evidence, but investigators found limited evidence for broader outpatient self-monitoring applications.
Google Trends data showed increased US search interest in vitamin A and cod liver oil during the 2025 measles outbreak, but normalized search data cannot determine actual product use, dosing behavior, or harms.
